Effect of Glycopyrrolate and Atropine on Catheter-Related Bladder Discomfort
NCT ID: NCT02228473
Last Updated: 2014-10-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
76 participants
INTERVENTIONAL
2014-09-30
2015-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Postoperative Urinary Retention in Patients After Noncardiac Surgery and Reversal of Neuromuscular Block
NCT05545280
Intrathecal Atropine Versus Intravenous Ondasetron in Post Operative Nausea Due to Intrathecal Morphine
NCT05137288
The Effect of Deep Neuromuscular Blockade on Requirement of Intravenous Anesthetic Agent
NCT03890406
Effect of Ketamine Added to Intravenous Patient-controlled Analgesia on Postoperative Pain, Nausea and Vomiting in Patients Undergoing Lumbar Spinal Surgery
NCT01394406
The Effect of Combining Aprepitant With Ondansetron in High-risk Patients for Postoperative Nausea and Vomiting
NCT01897337
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
We want to evaluate the efficacy of the glycopyrrolate and atropine for the prevention of catheter-related bladder discomfort.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Glycopyrrolate
Glycopyrrolate will be administered as the adjuncts of neuromuscular blocker reversal agent.
Glycopyrrolate
Glycopyrrolate will be administered.
Atropine
Atropine will be administered as the adjuncts of neuromuscular blocker reversal agent.
Atropine
Atropine will be administered.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Glycopyrrolate
Glycopyrrolate will be administered.
Atropine
Atropine will be administered.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA I-III
Exclusion Criteria
* Patients with obstruction of urinary tract
* Patients with neurogenic bladder
* Patients with severe obesity
* Patients with neurologic disorder
* Patients with chronic pain
* Patients with allergic history to atropine or glycopyrrolate
19 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hee-Pyoung Park, PhD
Role: PRINCIPAL_INVESTIGATOR
Seoul National University of Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University of Hospital
Seoul, Korea, Republic of, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Kim HC, Lim SM, Seo H, Park HP. Effect of glycopyrrolate versus atropine coadministered with neostigmine for reversal of rocuronium on postoperative catheter-related bladder discomfort in patients undergoing transurethral resection of bladder tumor: a prospective randomized study. J Anesth. 2015 Dec;29(6):831-5. doi: 10.1007/s00540-015-2064-2. Epub 2015 Aug 9.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CRBDGlycoAtr
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.